BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6430079)

  • 21. Efficacy of a new transdermal nitroglycerin patch (Deponit 10) for stable angina pectoris.
    Greco R; D'Alterio D; Schiattarella M; Boccia A; Greco L; Marsico F
    Am J Cardiol; 1988 Mar; 61(9):44E-51E. PubMed ID: 3126635
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The transdermal administration of nitrates: an overview.
    Demma FJ; Wilson RR
    Angiology; 1983 Jan; 34(1):1-10. PubMed ID: 6401950
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Discontinuous drug release as an alternative to interval therapy in the treatment of coronary heart disease with nitroglycerin patches].
    Reiniger G; Rudolph W
    Herz; 1987 Oct; 12(5):348-53. PubMed ID: 3119443
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intermittent transdermal nitroglycerin therapy in angina pectoris. Clinically effective without tolerance or rebound. Minitran Efficacy Study Group.
    Parker JO; Amies MH; Hawkinson RW; Heilman JM; Hougham AJ; Vollmer MC; Wilson RR
    Circulation; 1995 Mar; 91(5):1368-74. PubMed ID: 7867175
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute and sustained antianginal effects of nitroglycerin patches: objective evaluation with training-effect-eliminated exercise performance index.
    Dogar H; Güzelsoy D; Gültekin N; Gürses N; Demiroglu C
    Am J Cardiol; 1988 Mar; 61(9):39E-43E. PubMed ID: 3126634
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of nitroglycerin-TTS and long-acting nitroglycerin tablets in the treatment of angina pectoris: a double-blind controlled study.
    Karlson BW; Henning R
    Clin Cardiol; 1987 Oct; 10(10):573-7. PubMed ID: 3117467
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antianginal effects of intravenous nitroglycerin over 24 hours.
    Zimrin D; Reichek N; Bogin KT; Aurigemma G; Douglas P; Berko B; Fung HL
    Circulation; 1988 Jun; 77(6):1376-84. PubMed ID: 3131041
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A randomized placebo controlled, double-blind, crossover trial of transdermal nitroglycerin in stable angina pectoris.
    Rezaković DE; Pavicić L; Majacić M
    Eur Heart J; 1988 Jan; 9 Suppl A():73-81. PubMed ID: 3137073
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nitrates for angina pectoris. A critical review of therapeutic efficacy and tolerance.
    Thadani U
    Herz; 1984 Jun; 9(3):123-36. PubMed ID: 6430766
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical experience with a transdermal nitroglycerin system.
    Mahapatra RK; Mahapatra D; Yaden S
    Angiology; 1987 Apr; 38(4):277-86. PubMed ID: 3107441
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute and chronic efficacy of low-dose nitroglycerin patches in stable angina pectoris.
    Rezaković DE; Lakatos S; Stalec J; Pavicić L
    Z Kardiol; 1986; 75 Suppl 3():90-5. PubMed ID: 3099489
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glyceryl trinitrate (nitroglycerin) and the organic nitrates. Choosing the method of administration.
    Abrams J
    Drugs; 1987 Sep; 34(3):391-403. PubMed ID: 3119308
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of transdermal glyceryl trinitrate in the treatment of chronic stable angina pectoris.
    James MA; Walker PR; Papouchado M; Wilkinson PR
    Br Heart J; 1985 Jun; 53(6):631-5. PubMed ID: 3924081
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antianginal efficacy of ranolazine when added to treatment with amlodipine: the ERICA (Efficacy of Ranolazine in Chronic Angina) trial.
    Stone PH; Gratsiansky NA; Blokhin A; Huang IZ; Meng L;
    J Am Coll Cardiol; 2006 Aug; 48(3):566-75. PubMed ID: 16875985
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [High-dose transdermal nitroglycerin therapy: loss of effect within 24 hours?].
    Reiniger G; Kraus F; Dirschinger J; Blasini R; Rudolph W
    Herz; 1985 Jun; 10(3):157-62. PubMed ID: 3926612
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A multicenter trial of transdermal nitroglycerin in exercise-induced angina: individual antianginal response after repeated administration.
    Muiesan G; Agabiti-Rosei E; Muiesan L; Romanelli G; Pollavini P; Pasotti C; Fiori G; Muratori L; Zuarini AM; Pastorini C
    Am Heart J; 1986 Jul; 112(1):233-8. PubMed ID: 3088963
    [No Abstract]   [Full Text] [Related]  

  • 37. Influence of transdermal nitrates on exercise capacity in patients with stable angina.
    Thompson R
    Angiology; 1986 Jun; 37(6):448-54. PubMed ID: 3089073
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term efficacy of continuous and intermittent use of transdermal nitroglycerin in stable angina pectoris.
    de Milliano PA; Koster RW; Bär FW; Janssen J; de Cock C; Schelling A; van de Bos A
    Am J Cardiol; 1991 Oct; 68(9):857-62. PubMed ID: 1927943
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of sustained-release buccal nitroglycerin in patients with angina pectoris. New and long-acting therapy demonstrated by exercise.
    Greengart A; Lichstein E; Hollander G; Bolton S; Sanders M
    Chest; 1983 Mar; 83(3):473-9. PubMed ID: 6402342
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The development of tolerance to continuous transdermal nitroglycerin therapy in patients with angina of effort and mixed angina].
    Cianfrocca C; Sabia R; Zoboli S; Bugiardini R
    G Ital Cardiol; 1993 May; 23(5):439-49. PubMed ID: 8339869
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.